PSG is committed to educating the marketplace with timely insights and resources relevant to the pharmacy industry. Because this space is rapidly evolving, it is vital that our clients have access to fact-driven information. PSG understands that it can be difficult to navigate drug management challenges, and our extensive knowledge of the pharmaceutical supply chain enables us to help our clients anticipate the shifting landscape and turn challenges into opportunities.
PBM audits can help you address key contractual considerations such as rebates, specialty drug pricing, financial guarantees, erroneous claims, and more.
Download the Whitepaper
Learn about current drug pricing trends and valuable strategies plan sponsors can implement to offset rising drug costs through improved PBM contracting.
View the Webinar Recording
Take a few minutes and download our latest educational brief that outlines some of the latest audit trends and provide useful insights as to how covered entities can evolve their patient definitions to maintain compliance.
A report by PwC Health Research estimates U.S. specialty spending will quadruple to $401.7 billion from 2012 and 2020. Our team of industry experts compiled an overview of the impact of specialty on benefits management to help you make that shift.